
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+13
Humanity will always depend on medicines. Continuous innovation in the biotech sector is a given. Bringing better medicines to the market all the time. The Aescap Life Sciences and Aescap Genetics funds invest in highly innovative publicly traded biotech/life sciences companies. These companies are developing tomorrows medicines. Investing in Aescap funds offers the possibility to achieve excellent returns over the medium term, without taking large risks. Both funds have a focused portfolio, based on deep fundamental analyses and a strict buy and sell discipline. The Aescap funds act under the Article 8 of the EU Sustainable Finance Disclosure Regulation (SFDR)...
Biotech,fund management,life sciences,esg,article 8 sfdr,biotechfonds,public biotech,medicine,genetics,rna,gene therapy,patrick krol,genetics fund,healthcare,biotechfonds,biotech fonds,asset management,and active management
Aescap operates in the Investment management industry.
Aescap's revenue is 11m - 100m
Aescap has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.